Harvard technology provides early boost to Mass. COVID testing
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer insights into what the latest developments in the COVID-19 outbreak may bring. As Massachusetts rapidly ramps up COVID-19 testing, a technology born in the lab of Harvard AIDS pioneer Max Essex and nurtured by entrepreneurship resources on campus has played an important role in providing the needed reagents and kits that are driving a surge in testing. At Beth Israel Deaconess Medical Center, which by Sunday afternoon had conducted almost 2,500 tests, the most by a hospital-based lab in the state, the first kits that fed the hospital’s rapid increase in testing since mid-March came from Watertown-based Aldatu Biosciences. [The Broad Institute also has made rapid, large advances in testing.] The nine-employee company was formed to commercialize this diagnostic technology developed at Harvard and was based at the Pagliuca Harvard...